HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Methyldimethylaminoazobenzene

A very potent liver carcinogen.
Also Known As:
3'-Methyl-4-dimethylaminoazobenzene; Dimethyl-p-(m-tolylazo)aniline; 3' Methyl 4 dimethylaminoazobenzene; MeDAB; Benzenamine, N,N-dimethyl-4-((3-methylphenyl)azo)-
Networked: 86 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pakharukova, M Yu: 1 article (11/2011)
2. Ilnitskaya, S I: 1 article (11/2011)
3. Kaledin, V I: 1 article (11/2011)
4. Merkulova, T I: 1 article (11/2011)
5. Smetanina, M A: 1 article (11/2011)
6. Konishi, Yoichi: 1 article (01/2002)
7. Onishi, Shunzo: 1 article (01/2002)
8. Zeng, Zhao-Zhu: 1 article (01/2002)
9. Higashi, Ken: 1 article (01/2002)
10. Yan, Ying: 1 article (01/2002)

Related Diseases

1. Hepatocellular Carcinoma (Hepatoma)
2. Neoplasms (Cancer)
3. Experimental Liver Neoplasms
4. Liver Neoplasms (Liver Cancer)
5. Tetraploidy

Related Drugs and Biologics

1. Methyldimethylaminoazobenzene
2. Neuraminidase (Sialidase)
3. Immune Sera (Antisera)
4. aminohexyl-sepharose
5. Carcinogens
6. DNA (Deoxyribonucleic Acid)
7. alpha-Fetoproteins (AFP)
8. RNA (Ribonucleic Acid)
9. Nuclear RNA
10. Keratins (Keratin)

Related Therapies and Procedures

1. Oral Administration
2. Transplants (Transplant)
3. Ovariectomy (Oophorectomy)
4. Injections
5. Intra-Arterial Infusions